To report an adverse event or product quality issue, please email us at reportnow@argenx.com or call us at 1-833-274-9411.
©2026 argenx | Disclaimer | Privacy Policy | Regulations | U.S. Supplemental Privacy Notice
Arjen Lemmen serves as Vice President of Corporate Development & Strategy at argenx, which he joined in 2016. In his role, he has successfully executed several transactions including a number of programs within the Immunology Innovation Program and the strategic collaboration with Janssen for cusatuzumab.
Prior to joining argenx, Arjen served as a corporate finance specialist at Kempen & Co focusing on M&A, Equity Capital Markets, and strategic advisory transactions in the European life sciences industry. He holds a B.Sc. in Life Science & Technology from the University of Groningen and a Master of Engineering Management from Duke University.
At argenx, every piece of the innovation story connects. See where it leads next.
Funding research, education, and initiatives that raise the standard of care.
Discover why we’re more than a unique name.
The latest news and press releases from argenx.